Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01709773 · ClinicalTrials.gov registry record · NA
Focal Ablation of Cervical Precancer
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01709773 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 20 participants.
The verdict
NCT01709773, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a pilot cohort study of women undergoing focal ablation for high-grade cervical intraepithelial neoplasia (HGCIN). The cohort was recruited from the UCSF Dysplasia Clinics. The standard treatment involves treatment of the entire cervix. Women with HGCIN meeting inclusion criteria were recruited for enrollment into the pilot study of focal treatment. Upon enrollment, they underwent focal ablational treatment rather than standard ablational treatment of the cervix. Follow-up visits were conducted at 2 weeks and 6 months to assess safety, feasibility, and acceptability. The 6-month recurrence rate of HGCIN will be calculated.
Interventions
- PROCEDURE Focal treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-01-17 |
| Est. Completion | 2014-05-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01709773
The ClinicalTrials.gov registry entry for NCT01709773 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Focal treatment is the first listed.
NCT01709773 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01709773 about?
NCT01709773 is a clinical study titled "Focal Ablation of Cervical Precancer". This is a pilot cohort study of women undergoing focal ablation for high-grade cervical intraepithelial neoplasia (HGCIN). The cohort was recruited from the UCSF Dysplasia Clinics. The standard treatment involves treatment of the entire cervix. Women with HGCIN meeting inclusion criteria were recrui...
What is the current status of trial NCT01709773?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-01-17. Estimated completion is 2014-05-26.
What interventions are being tested in trial NCT01709773?
The interventions under investigation include: Focal treatment (PROCEDURE).
Who is sponsoring clinical trial NCT01709773?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.